Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Food Additive and Color Additive Petitions Under Review or Held in Abeyance
  • Print
  • Share
  • E-mail
-

May 28, 2026

The following table is a listing of food additive and color additive petitions filed by FDA's Office of Food Additive Safety (OFAS) that are either under active review or held in abeyance as of the date shown above. This list does not reflect petitions filed after that date, or any change in status for the listed petitions that has occurred after that date.

Abeyance is an administrative category of petitions that are filed but non-active because of deficiencies that were identified during FDA’s review. A petition remains in abeyance until either the petitioner provides OFAS with the required information, requests a final decision based on the data currently in the petition, or requests withdrawal of the petition. When the petitioner provides the information required to address all deficiencies, the petition may be refiled resulting in a new filing date.

More information about Food Additives and Petitions.

Search and display hints:

  • To sort by a specific field, click on the column header for that field.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term.
  • Click on the petition number to access details about the petition.
Search within these results
Records Found: 1316 Show All Page 1 of 27
GRN No.
(sorted Z-A) 		Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
1316 Saccharomyces cerevisiae “BY-1574” expressing a gene encoding an alcohol-O-acyltransferase enzyme from Cucumis melo var. Cantalupensis Pending
1315 Short-chain chondroitin sulfate oligosaccharides produced from enzymatic hydrolysis of chondroitin sulfate Pending
1314 Bacillus pumilus SG154 Pending
1313 Algal oil (≥35% docosahexaenoic acid) from Schizochytrium limacinum CCAP A2 Pending
1312 Recombinant αS1-casein from Bos taurus produced by Escherichia coli DSM 35603 Pending
1311 L-theanine produced by Escherichia coli CICC 11189s Pending
1310 Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Pending
1309 D-psicose Pending
1308 β-glucan produced by Kluyveromyces marxianus CGMCC 26703 Pending
1307 Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Pending
1306 Subtilisin enzyme preparation produced by Bacillus paralicheniformis Pending
1305 Brazzein preparation produced by Komagataella phaffii GDMCC 70101 expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
1304 Preparation containing at least three bacteriophages (phage) specific to Listeria spp. Pending
1303 Bifidobacterium animalis subsp. lactis CGMCC5470 May 11, 2026 FDA has no questions (in PDF)240 kB
1302 Fermented grape pomace Pending
1301 Algal oil (≥45% docosahexaenoic acid from Schizochytrium sp. JDW-108) Pending
1300 Zeaxanthin produced via fermentation using production strain Yarrowia lipolytica CGMCC 39021 May 15, 2026 FDA has no questions (in PDF)194 kB
1299 3′-sialyllactose sodium salt produced via fermentation using production strain Escherichia coli “SLIS109” May 13, 2026 FDA has no questions (in PDF)299 kB
1298 2'-fucosyllactose Pending
1297 Enzyme-hydrolyzed brown rice protein Pending
1296 Erythritol produced through fermentation of glucose by Yarrowia lipolytica Pending
1295 Brazzein preparation produced by Komagataella phaffii GS115 expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
1294 Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Apr 16, 2026 FDA has no questions (in PDF)191 kB
1293 Brazzein preparation produced by Komagataella phaffii RA-b expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
1292 Citrus-derived compounded sweetener made with neohesperidin dihydrochalcone and gamma cyclodextrin Apr 28, 2026 FDA has no questions (in PDF)631 kB
1291 Wattle (Acacia longifolia) seeds Pending
1290 Glucose oxidase enzyme preparation produced by Komagataella phaffii expressing a gene encoding glucose oxidase from Aspergillus niger May 6, 2026 FDA has no questions (in PDF)201 kB
1289 Protein-glutamine glutaminase enzyme preparation produced by Bacillus licheniformis expressing a gene encoding protein-glutamine glutaminase from Chryseobacterium viscerum Pending
1288 Enzyme-modified steviol glycosides Feb 17, 2026 FDA has no questions (in PDF)220 kB
1287 Sucrose oligoesters Mar 23, 2026 FDA has no questions (in PDF)234 kB
1286 Brazzein preparation produced by Zea mays expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
1285 Saccharomyces cerevisiae BY-927 expressing a gene encoding α-acetolactate decarboxylase enzyme from Acetobacter aceti Mar 9, 2026 FDA has no questions (in PDF)255 kB
1284 Recombinant bovine lactoferrin isolate produced by Komagataella phaffii Ppas_337 expressing the gene encoding bovine lactoferrin Mar 25, 2026 FDA has no questions (in PDF)201 kB
1283 Bacillus coagulans BC99 spore preparation Mar 18, 2026 FDA has no questions (in PDF)256 kB
1282 Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Jan 12, 2026 FDA has no questions (in PDF)257 kB
1281 2'-Fucosyllactose May 8, 2026 Notice does not provide a basis for a GRAS determination (in PDF)198 kB
1280 Pleurotus pulmonarius mycelia and Chlorella vulgaris microalgae Pending
1279 Saccharomyces cerevisiae CCTCC M2025194 Mar 23, 2026 FDA has no questions (in PDF)189 kB
1278 Lactiplantibacillus plantarum CGMCC 6312 Mar 31, 2026 FDA has no questions (in PDF)291 kB
1277 Autoclaved Parabacteroides goldsteinii RV-01 Jan 22, 2026 At the notifier's request, FDA ceased to evaluate this notice (in PDF)293 kB
1276 Cellulase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a cellulase from Aspergillus niger Apr 8, 2026 FDA has no questions (in PDF)260 kB
1275 6'-Sialyllactose sodium salt Mar 20, 2026 FDA has no questions (in PDF)277 kB
1274 2'-Fucosyllactose Dec 8, 2025 FDA has no questions (in PDF)353 kB
1273 Lacto-N-tetraose Apr 8, 2026 FDA has no questions (in PDF)295 kB
1272 Lacto-N-neotetraose Apr 8, 2026 FDA has no questions (in PDF)293 kB
1271 Short-chain fructooligosaccharides Mar 18, 2026 FDA has no questions (in PDF)234 kB
1270 L-ergothioneine produced by Escherichia coli K-12 MG1655 expressing enzymes from Neurospora crassa and Mycolicibacterium smegmatis MC2 155 Jan 22, 2026 FDA has no questions (in PDF)230 kB
1269 Monellin preparation produced by Komagataella phaffii CBS 150005 expressing a gene encoding for a modified monellin Feb 4, 2026 FDA has no questions (in PDF)256 kB Feb 5, 2026
1268 Mycelial biomass from Rhizomucor pusillus Mar 3, 2026 At the notifier's request, FDA ceased to evaluate this notice (in PDF)158 kB
1267 Sunflower lecithin Feb 17, 2026 FDA has no questions (in PDF)204 kB

Show All 

jump to page of 27 

GRN No.
(sorted Z-A) 		Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-